1. Home
  2. UG vs ECOR Comparison

UG vs ECOR Comparison

Compare UG & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • ECOR
  • Stock Information
  • Founded
  • UG 1942
  • ECOR 2005
  • Country
  • UG United States
  • ECOR United States
  • Employees
  • UG N/A
  • ECOR N/A
  • Industry
  • UG Package Goods/Cosmetics
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • UG Consumer Discretionary
  • ECOR Health Care
  • Exchange
  • UG Nasdaq
  • ECOR Nasdaq
  • Market Cap
  • UG 36.4M
  • ECOR 40.0M
  • IPO Year
  • UG N/A
  • ECOR 2018
  • Fundamental
  • Price
  • UG $7.23
  • ECOR $4.95
  • Analyst Decision
  • UG
  • ECOR Strong Buy
  • Analyst Count
  • UG 0
  • ECOR 2
  • Target Price
  • UG N/A
  • ECOR $25.50
  • AVG Volume (30 Days)
  • UG 6.4K
  • ECOR 42.9K
  • Earning Date
  • UG 11-11-2025
  • ECOR 11-05-2025
  • Dividend Yield
  • UG 9.59%
  • ECOR N/A
  • EPS Growth
  • UG N/A
  • ECOR N/A
  • EPS
  • UG 0.56
  • ECOR N/A
  • Revenue
  • UG $10,856,174.00
  • ECOR $27,700,000.00
  • Revenue This Year
  • UG N/A
  • ECOR $23.74
  • Revenue Next Year
  • UG N/A
  • ECOR $42.02
  • P/E Ratio
  • UG $13.12
  • ECOR N/A
  • Revenue Growth
  • UG N/A
  • ECOR 30.16
  • 52 Week Low
  • UG $7.25
  • ECOR $4.16
  • 52 Week High
  • UG $14.05
  • ECOR $19.49
  • Technical
  • Relative Strength Index (RSI)
  • UG 42.03
  • ECOR 46.26
  • Support Level
  • UG $7.36
  • ECOR $4.88
  • Resistance Level
  • UG $7.49
  • ECOR $5.19
  • Average True Range (ATR)
  • UG 0.15
  • ECOR 0.22
  • MACD
  • UG -0.00
  • ECOR 0.00
  • Stochastic Oscillator
  • UG 11.16
  • ECOR 34.40

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Share on Social Networks: